Parataxis Holdings LLC has entered into a definitive agreement to acquire a controlling interest in South Korean biotech company Bridge Biotherapeutics, Inc. (KOSDAQ: 288330) for KRW 25 billion ($18.3 million),…
Parataxis Holdings LLC has made a deal with Bridge Biotherapeutics Inc. to take control of the company with a KRW 25 billion ($18.2 million) investment. Plarataxis plans to turn the…
Parataxis Holdings, an affiliate of digital asset-focused investment company Parataxis Capital Management, is set to launch a Bitcoin-native treasury platform in the South Korean public market.The firm announced on Friday…